Journal article
A Redox-Shifted Fibroblast Subpopulation Emerges in the Fibrotic Lung
American journal of respiratory cell and molecular biology, Vol.71(6), pp.718-729
12/01/2024
DOI: 10.1165/rcmb.2023-0346OC
PMCID: PMC11622638
PMID: 38959411
Abstract
Idiopathic pulmonary fibrosis (IPF) is an aggressive and, thus far, incurable disease characterized by aberrant fibroblast-mediated extracellular matrix deposition. Our understanding of the disease etiology is incomplete; however, there is consensus that a reduction-oxidation (redox) imbalance plays a role. In this study, we use the autofluorescent properties of two redox molecules, NAD(P)H and FAD, to quantify changes in their relative abundance in living lung tissue of mice with experimental lung fibrosis and in freshly isolated cells from mouse lungs and humans with IPF. Our results identify cell population-specific intracellular redox changes in the lungs in experimental and human fibrosis. We focus particularly on redox changes within collagen-producing cells, where we identified a bimodal distribution of NAD(P)H concentrations, establishing NAD(P)H
and NAD(P)H
subpopulations. NAD(P)H
fibroblasts exhibited elevated profibrotic gene expression and decreased collagenolytic protease activity relative to NAD(P)H
fibroblasts. The NAD(P)H
population was present in healthy lungs but expanded with time after bleomycin injury, suggesting a potential role in fibrosis progression. We identified a similar increased abundance of NAD(P)H
cells in freshly dissociated lungs of subjects with IPF relative to control subjects, as well as similar reductions in collagenolytic activity in this cell population. These data highlight the complexity of redox state changes in experimental and human pulmonary fibrosis and the need for selective approaches to restore redox imbalances in the fibrotic lung.
Details
- Title: Subtitle
- A Redox-Shifted Fibroblast Subpopulation Emerges in the Fibrotic Lung
- Creators
- Patrick A Link - Mayo ClinicJeffrey A Meridew - Mayo ClinicNunzia Caporarello - Loyola University ChicagoAshley Y Gao - Mayo ClinicVictor Peters - The Ohio State UniversityMauricio Rojas - The Ohio State UniversityDaniel J Tschumperlin - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- American journal of respiratory cell and molecular biology, Vol.71(6), pp.718-729
- DOI
- 10.1165/rcmb.2023-0346OC
- PMID
- 38959411
- PMCID
- PMC11622638
- NLM abbreviation
- Am J Respir Cell Mol Biol
- ISSN
- 1044-1549
- eISSN
- 1535-4989
- Grant note
- R01 HL092961 / NHLBI NIH HHS National Heart, Lung and Blood Institute F32 HL158018 / NHLBI NIH HHS R01 HL166187 / NHLBI NIH HHS R01 HL153026 / NHLBI NIH HHS T32 HL105355 / NHLBI NIH HHS U01 HL152967 / NHLBI NIH HHS
- Language
- English
- Date published
- 12/01/2024
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Craniofacial Anomalies Research Center
- Record Identifier
- 9984948141702771
Metrics
42 Record Views